MDRX Investors Have Opportunity to Lead Veradigm Inc. Securities Fraud Lawsuit
LOS ANGELES, Jan. 16, 2024 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Veradigm Inc. ("Veradigm" or the "Company") (NASDAQ: MDRX).
Class Period: February 26, 2021 – December 7, 2023
Lead Plaintiff Deadline:January 22, 2024
If you are a shareholder who suffered a loss, click here to participate.
The complaint filed alleges that, throughout the Class Period, Defendants failed to disclose to investors that: (1) Veradigm had overstated its historical revenues by at least $20 million; (2) Veradigm had artificially inflated its revenue by recording duplicate transactions, among other things, over a more than two-year period; (3) Veradigm had artificially inflated its earnings and margins and materially misrepresented demand for the Company's products and services during the Class Period; (4) Veradigm had failed to maintain effective internal controls over its financial reporting; (5) Veradigm had failed to comply with Generally Accepted Accounting Principles ("GAAP") regarding appropriate revenue recognition practices; and (6) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.
Follow us for updates on Twitter: twitter.com/FRC_LAW.
To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 2121 Avenue of the Stars, Suite 800, Century City, California 90067 at 310-914-5007, by email to info@frankcruzlaw.com, or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
View original content to download multimedia:https://www.prnewswire.com/news-releases/mdrx-investors-have-opportunity-to-lead-veradigm-inc-securities-fraud-lawsuit-302036246.html
SOURCE The Law Offices of Frank R. Cruz, Los Angeles
Ausgewählte Hebelprodukte auf Allscripts Healthcare Solutions
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Allscripts Healthcare Solutions
Der Hebel muss zwischen 2 und 20 liegen
Aktuelle Allscripts Healthcare Solutions Aktie News
Allscripts Healthcare Solutions Analysen
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Allscripts Healthcare Solutions nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen
| Datum | Rating | Analyst | |
|---|---|---|---|
| 02.11.18 | Allscripts Healthcare Solutions Neutral | Cantor Fitzgerald | |
| 19.09.17 | Allscripts Healthcare Solutions Outperform | RBC Capital Markets | |
| 15.08.17 | Allscripts Healthcare Solutions Overweight | Cantor Fitzgerald | |
| 10.01.17 | Allscripts Healthcare Solutions Buy | Maxim Group | |
| 02.12.16 | Allscripts Healthcare Solutions Neutral | Dougherty & Company LLC |
